# Cognito Therapeutics funding rounds and investors

As of 14 Oct 2026, Cognito Therapeutics has raised $105M across 1 verified round on record; latest: $105 million Series C led by IAG Capital Partners, Morningside Group and 1 other, announced 5 Mar 2026.

Cognitotx sells a non-invasive neuroprotective therapy platform designed to evoke brain wave activity to benefit Alzheimer's patients.

Website: https://cognitotx.com  
Headquarters: Cambridge, MA  
Page: https://fireround.dev/companies/cognitotx.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-03-05 | Series C | $105 million | IAG Capital Partners, Morningside Group, Starbloom Capital | Apollo Health Ventures, Benvolio Group, New Vintage | [businesswire.com](https://www.businesswire.com/news/home/20260305121811/en/Cognito-Therapeutics-Announces-Oversubscribed-%24105-Million-Series-C-Financing-to-Advance-Spectris-in-Alzheimers-Disease) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.